OVERVIEW
TEAM
Our mission is to discover, develop and deliver innovative therapeutics
for patients suffering from cancer and other incurable diseases.
-
SEUNGWAN KANG CEO & CTO
EDUCATION
- Department of Chemistry, Korea University, M.S.
(2002-2004) - Department of Chemistry, Korea University, B.S.
(1995-2002)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, CEO & CTO (2020~present)
- Drug Discovery Center, Life Sciences R&D, LG Chem, Senior Research Scientist (2017~2019)
- Drug Discovery R&D Center, LG Life Sciences, Senior Research Scientist (2004~2016)
- Department of Chemistry, Korea University, M.S.
-
DR. HYUN SEOK KIM FOUNDER & CSO
EDUCATION
- University of Texas Southwestern Medical Center, Postdoc (2008~2014)
- Washington University in St. Louis, Computational Biology, Ph.D. (2003~2008)
- Department of Microbiology, Seoul National University, B.S, M.S. (1991~1997)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, CSO (2019~present)
- Yonsei University College of Medicine, Assistant professor, Associate professor (2014~present)
- R&D Center of Pharmaceuticals, CJ Institute of Science & Technology, Research Scientist (1997~2003)
-
DR. JOOYOUNG LEE BIOLOGY, EXECUTIVE DIRECTOR
EDUCATION
- Division of Life and Pharmaceutical Sciences, Ewha Woman’s University, M.S. (2005~2007), Ph.D. (2008~2012)
- Department of life science, Ewha Woman’s University, B.S. (2001-2005)
PROFESSIONAL EXPERIENCE
- Checkmate Therapeutics, Executive Director (2020~present)
- Yonsei University College of Medicine, Assistant research professor (2018~2019)
- Yonsei University College of Medicine, Postdoctal fellow (2014~2017)